Literature DB >> 25640099

The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.

Sarah Weiling Li, Angela Natalie Barrett, Leena Gole, Wei Ching Tan, Arijit Biswas, Hak Koon Tan, Mahesh Choolani1.   

Abstract

INTRODUCTION: First trimester screening (FTS) is a validated screening tool that has been shown to achieve detection rates of 84%-90% for trisomies 21, 18 and 13. However, its effectiveness for different maternal ages has not been assessed. The present study aimed to assess the performance of FTS in an Asian population, and to compare its effectiveness in older (≥ 35 years) and younger (< 35 years) women. The potential use of noninvasive prenatal test (NIPT) as a contingent screening test is also examined.
METHODS: Data on cases of FTS performed on singleton pregnancies over a six-year period was collated from two Singapore maternal centres, National University Hospital and Singapore General Hospital. Cases that had a 1:250 risk of trisomy were considered to be screen-positive. Pregnancy outcomes were obtained from birth records or karyotype test results.
RESULTS: From 10,289 FTS cases, we obtained a sensitivity of 87.8%, a specificity of 97.6%, a false positive rate of 2.4% and a false negative rate of 0.06% for the detection of aneuploidy. The overall detection rate for trisomy 21 was 86.5%-85.7% for older women and 87.5% for younger women. The mean number of invasive tests required per case of trisomy 21 was 9.3 in younger women, 8.6 in older women and 13.5 in women with intermediate risk (1:250-1,000).
CONCLUSION: While the performance of FTS was similar in younger and older women, more invasive procedures were required to diagnose trisomy 21 in women with intermediate risk. It may be advantageous to offer contingent NIPT to this group of women to reduce the risk of iatrogenic fetal loss.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640099      PMCID: PMC4325570          DOI: 10.11622/smedj.2015009

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  25 in total

1.  Validation of first trimester screening for trisomy 21 in Singapore with reference to performance of nasal bone.

Authors:  George Seow Heong Yeo; Fon-Min Lai; Xing Wei; Padma Lata; Doreen Tsai Hia Tan; Min Hwee Yong; Edward Teck Hoo Tan; Kenneth Yung Chiang Kwek
Journal:  Fetal Diagn Ther       Date:  2012-06-15       Impact factor: 2.587

2.  First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases.

Authors:  Tak Yeung Leung; Lin Wai Chan; Lai Wa Law; Daljit Singh Sahota; Tak Yuen Fung; Tse Ngong Leung; Tze Kin Lau
Journal:  J Matern Fetal Neonatal Med       Date:  2009-04

3.  Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

Authors:  Mary E Norton; Herb Brar; Jonathan Weiss; Ardeshir Karimi; Louise C Laurent; Aaron B Caughey; M Hellen Rodriguez; John Williams; Michael E Mitchell; Charles D Adair; Hanmin Lee; Bo Jacobsson; Mark W Tomlinson; Dick Oepkes; Desiree Hollemon; Andrew B Sparks; Arnold Oliphant; Ken Song
Journal:  Am J Obstet Gynecol       Date:  2012-06-01       Impact factor: 8.661

4.  First-trimester Down syndrome screening in women younger than 35 years old and cost-effectiveness analysis in Taiwan population.

Authors:  Ching-Yu Chou; Fon-Jou Hsieh; Mei-Leng Cheong; Fa-Kung Lee; Bo-Quing She; Ming-Song Tsai
Journal:  J Eval Clin Pract       Date:  2009-10       Impact factor: 2.431

5.  Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Authors:  Diana W Bianchi; Lawrence D Platt; James D Goldberg; Alfred Z Abuhamad; Amy J Sehnert; Richard P Rava
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

6.  Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy.

Authors: 
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

7.  First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age.

Authors:  Sini Peuhkurinen; Paivi Laitinen; Markku Ryynanen; Jaana Marttala
Journal:  J Eval Clin Pract       Date:  2012-03-27       Impact factor: 2.431

8.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Authors:  Rossa W K Chiu; Ranjit Akolekar; Yama W L Zheng; Tak Y Leung; Hao Sun; K C Allen Chan; Fiona M F Lun; Attie T J I Go; Elizabeth T Lau; William W K To; Wing C Leung; Rebecca Y K Tang; Sidney K C Au-Yeung; Helena Lam; Yu Y Kung; Xiuqing Zhang; John M G van Vugt; Ryoko Minekawa; Mary H Y Tang; Jun Wang; Cees B M Oudejans; Tze K Lau; Kypros H Nicolaides; Y M Dennis Lo
Journal:  BMJ       Date:  2011-01-11

9.  Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.

Authors:  A Tabor; C H F Vestergaard; Ø Lidegaard
Journal:  Ultrasound Obstet Gynecol       Date:  2009-07       Impact factor: 7.299

10.  Prospective validation of first-trimester combined screening for trisomy 21.

Authors:  K O Kagan; A Etchegaray; Y Zhou; D Wright; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2009-07       Impact factor: 7.299

View more
  4 in total

1.  Combined first trimester screen or noninvasive prenatal testing or both.

Authors:  Tony Yew Teck Tan
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

2.  Comment on: The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.

Authors:  Fon-Min Lai; George S H Yeo
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

3.  Authors' Reply: The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.

Authors:  Angela Natalie Barrett; Sarah Weiling Li; Leena Gole; Wei Ching Tan; Arijit Biswas; Hak Koon Tan; Mahesh Choolani
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

4.  Study on the Clinical Value of Noninvasive Prenatal Testing in Screening the Chromosomal Abnormalities of the Fetus in the Elderly Pregnant Women.

Authors:  Zhiping Gu; Mengmeng Du; Tianhui Xu; Chunyan Jin
Journal:  Comput Math Methods Med       Date:  2022-09-28       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.